March 23, 2020 / 12:19 PM / 16 days ago

BRIEF-Novan Announces Data From B-Simple Week 24 Safety Evaluation And COVID-19 Business Updates

March 23 (Reuters) - Novan Inc:

* NOVAN ANNOUNCES DATA FROM B-SIMPLE WEEK 24 SAFETY EVALUATION AND COVID-19 BUSINESS UPDATES

* NOVAN INC - NOVAN INTENDS TO SCREEN NVN1000 AGAINST A NUMBER OF VIRUSES, INCLUDING SARS-COV-2

* NOVAN INC - FAVORABLE SB206 WEEK 24 SAFETY AND SCARRING PROFILES SEEN IN STUDY

* NOVAN INC - TYPE C TELECONFERENCE WITH FDA FOR SB206 REMAINS SCHEDULED ON APRIL 1, 2020

* NOVAN INC - INTENDS TO EXPLORE USE OF NITRICIL TECHNOLOGY TO PROGRESS A POTENTIAL TOPICAL ORAL OR NASAL TREATMENT OPTION FOR COVID-19

* NOVAN INC - INITIATED WORK ORDER TO COMPLETE IN VITRO ASSESSMENT OF NITRICIL TECHNOLOGY, BERDAZIMER SODIUM AGAINST SPECIES WITHIN CORONAVIRIDAE FAMILY

* NOVAN INC - EXPLORING POTENTIAL FOR FEDERAL GRANTS TO SUPPORT EFFORTS. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below